Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase

Journal of Autoimmunity

Volumn 9, Issue 5, 1996, Pages 683-688

  Abiru, Norio ^a   Takino, Hirofumi ^a   Yano, Mayumi ^a   Kawasaki, Eiji ^a   Yamasaki, Hironori ^a   Yamaguchi, Yoshihiko ^a   Akazawa, Shoichi ^a   Nagataki, Shigenobu ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glutamic acid decarboxylase antibodies; Insulin dependent diabetes mellitus; Islet cell antibodies; Non insulin dependent diabetes mellitus

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; JAPAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RISK;

EID: 0030272109     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0089     Document Type: Article

References (30)

1. 1. Eisenbarth G.S. 1986. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
2. 2. Kahn C.R. 1994. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084
3. 3. Irvine W.J., Gray R.S., McCallum C.J., Duncan L.J.P. 1977. Clinical and pathogenetic significance of pancreatic islet cell antibodies in diabetes treated with oral hypoglycemic agents. Lancet 1: 1025-1027
4. 4. Irvine W.J., Sawers J.S.A., Feek C.M., Prescott A.J., Duncan L.P.J. 1979. The value of islet cell antibody in predicting secondary failure of oral hypoglycemic agent therapy in diabetes mellitus. J. Clin. Lab. Immunol. 2: 23-26
5. 5. Di Mario, Irvine W.J., Borsey D.Q., Kyner J.L., Weston J., Galfo C. 1983. Immune abnormalities in diabetic patients not requiring insulin at diagnosis. Diabetologia 25: 392-395
6. 6. Groop L.C., Miettinen A., Groop P., Meri S., Koskimies S., Bottazzo G.F. 1988. Organ-specific autoimmunity and HLA-DR antigens as markers for β-cell destruction in patients with type II diabetes. Diabetes 37: 99-103
7. 7. Groop L.C., Bottazzo G.F., Doniach D. 1986. Islet cell antibodies identify latent type I diabetes in patients aged 35-75 years at diagnosis. Diabetes 35: 237-241
8. 8. Tuomi T., Groop L.C., Zimmet P.Z., Rowley M.J., Knowles W., Mackay I.R. 1993. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42: 359-362
9. 9. Zimmet P.Z., Tuomi T., Mackay I.R., Rowley M.J., Knowles W., Cohen M., Lang D.A. 1994. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabetic Medicine 11: 299-303
10. 10. Hagopian W.A., Karlsen A.E., Gottsäter A., Landin-Olsson M., Grubin C.E., Sundkvist G., Petersen J.P., Boel E., Dyrberg T., Lernmark A. 1993. Quantitative assay using recombinant human islet glutamic acid decarboxylase (GAD65) shows that 64K autoantibody positive at onset predicts diabetes type. J. Clin. Invest. 91: 368-374
11. 11. Kosaka K., Hagura R., Kuzuya T. 1977. Insulin response in equivocal and definite diabetes with special reference to subjects who had mild glucose tolerance but later developed definite diabetes. Diabetes 26: 944-952
12. 12. Kadowaki T., Miyake Y., Hagura R., Akanuma Y., Kajinuma H., Kuzuya N., Takaku F., Kosaka K. 1984. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia 26: 44
13. 13. Eto K., Sakura H., Shimokawa K., Shimokawa K., Kadowaki H., Hagura R., Akanuma Y., Yazaki Y., Kadowaki T. 1993. Sequence variation of the glucokinase gene in Japanese subjects with NIDDM. Diabetes 42: 1133-1137
14. 14. Kadowaki T., Kadowaki H., Mori Y., Tobe K., Sakuta R., Suzuki Y., Tanabe Y., Sakura H., Awata T., Goto Y., Hayakawa T., Matsuoka K., Kawamori R., Kamada T., Horai S., Nonaka I., Hagura R., Akanuma Y., Yazaki Y. 1994. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N. Engl. J. Med. 330: 962-968
15. Leu (UUR) gene mutation in Japanese patients. Diabetologia 37: 504-510
16. 16. Kobayashi T., Itoh T., Kosaka K., Sato K., Tsuji K. 1987. Time course of islet cell antibodies and β-cell function in non-insulin-dependent stage of Type I diabetes. Diabetes 36: 510-517
17. 17. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M. 1994. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310
18. 18. National Diabetes Data Group. 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
19. 19. Hoogwerf B.J., Rich S.S., Barbosa J.J. 1985. Meal-stimulated C-peptide and insulin antibodies in Type I diabetic subjects and their nondiabetic siblings characterized by HLA-DR antigens. Diabetes 34: 440-445
20. 20. Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., Yamaguchi Y., Akazawa S., Nagataki S. 1994. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86
21. 21. Schmidli R.S., Colman P.G., Bonifacio E., Participating Laboratories. 1995. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies: The second international GADAb Workshop. Diabetes 44: 636-640
22. 22. Takahashi A., Tsujihata M., Yokota A., Yamaguchi Y., Ueda Y., Akazawa S., Miyake S., Nagataki S. 1986. A new method of detection of islet cell antibodies (ICA) using peroxidase-labeled protein A, and incidence of ICA in Type 1 (insulin-dependent) diabetes. Diabetologia 29: 378-382
23. 23. Beever K., Bradbury J., Phillips D., McLachlan S.M., Pegg C., Goral A., Overbeck W., Feifel G., Smith B.R. 1989. Highly sensitive assays of autoantibodies to thyroglobin and to thyroid peroxidase. Clin. Chem. 35: 1949-1954
24. 24. Nakagawa S. 1994. Insulin treatment in Japan. Diab. Res. Clin. Pract. 24 Supp.: 247-250
25. 25. Roll U., Gerlach E., Nuber A., Janka H.U., Schröder A., Ziegler A.G. 1995. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM. Diabetes Care 18: 210-215
26. 26. Yamaguchi Y., Chikuba N., Ueda Y., Yamamoto H., Yamasaki H., Nakanishi T., Akazawa S., Nagataki S. 1991. Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 40: 319-322
27. 27. Kawasaki E., Moriuchi R., Takino H., Okuno S., Takao Y., Maeda Y., Yokota A., Yamamoto H., Chikuba N., Akazawa S., Miyamoto T., Nagataki S. 1992. Autoantibodies to 64,000-Mr islet cell protein in long-term Type I (insulin-dependent) diabetic patients. Diabetologia 35: 748-752
28. 28. Wagner R., Genovese S., Bosi E., Becker F., Bingley P.J., Bonifacio E., Miles K.A., Christie M.R., Bottazzo G.F., Gale E.A.M. 1994. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease. Diabetologia 37: 365-371
29. 29. Tanguchi A., Nakai Y., Fukushima M., Kawamura H., Imura H., Nagata I., Tokuyama K. 1992. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41: 1540-1546
30. 30. Aanstoot H.J., Sigurdsson E., Jaffe M., Shi Y., Christgau S., Grobbee D., Bruining G.J., Molenar J.L., Hofman A., Baekkeskov S. 1994. Value of antibodies to GAD65 combines with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37: 917-924